Fireside Chat: Recursion CEO and President Najat Khan, PhD and Katie Couric at JPM 2026

At Recursion's event at the 2026 J.P. Morgan Healthcare Conference, Katie Couric, award-winning journalist, filmmaker, podcaster, and co-founder of Stand Up to Cancer, interviewed Recursion CEO and President Najat Khan about her vision for the company, the latest positive clinical results from Recursion's REC-4881 AI-identified drug for patients with FAP, and how investors and partners can separate hype from real AI breakthroughs.